References
- Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. 1998. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 339:1415–1425.
- Golledge J, Greenhalgh RM, Davies AH. 2000. The symptomatic carotid plaque. Stroke. 31:774–781.
- Spence JD. 2013. Intensive risk factor control in stroke prevention. F1000prime Rep. 5:42.
- Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, et al. 2006. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke. 37:818–823.
- Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcomb R, et al. 2013. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 61:1041–1051.
- Varetto G, Gibello L, Castagno C, Quaglino S, Ripepi M, Benintende E, et al. 2015. Use of contrast-enhanced ultrasound in carotid atherosclerotic disease: limits and perspectives. BioMed Res Int. 2015:293163.
- Kappelle LJ. 2002. Symptomatic carotid artery stenosis. J Neurol. 249:254–259.
- Ijas P, Nuotio K, Saksi J, Soinne L, Saimanen E, Karjalainen-Lindsberg ML, et al. 2007. Microarray analysis reveals overexpression of CD163 and HO-1 in symptomatic carotid plaques. Arterioscler Thromb Vasc Biol. 27:154–160.
- Ayari H, Bricca G. 2013. Identification of two genes potentially associated in iron-heme homeostasis in human carotid plaque using microarray analysis. J Biosci. 38:311–315.
- Gautier L, Cope L, Bolstad BM, Irizarry RA. 2004. affy – analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 20:307–315.
- Diboun I, Wernisch L, Orengo CA, Koltzenburg M. 2006. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 7:252.
- Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4:P3.
- Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, et al. 2011. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39:D561–D568.
- Libby P, Tabas I, Fredman G, Fisher EA. 2014. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res. 114:1867–1879.
- Evans NR, Tarkin JM, Chowdhury MM, Warburton EA, Rudd JH. 2016. PET imaging of atherosclerotic disease: advancing plaque assessment from anatomy to pathophysiology. Curr Atheroscler Rep. 18:30.
- Hansson GK, Libby P, Tabas I. 2015. Inflammation and plaque vulnerability. J Intern Med. 278:483–493.
- Baber U, Mehran R, Sartori S, Schoos MM, Sillesen H, Muntendam P, et al. 2015. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol. 65:1065–1074.
- Chung JW, Park SH, Kim N, Kim WJ, Park JH, Ko Y, et al. 2014. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification and vascular territory of ischemic stroke lesions diagnosed by diffusion-weighted imaging. J Am Heart Assoc. 3:pii: e001119. doi: 10.1161/JAHA.114.001119.
- Polyzos KA, Ketelhuth DF. 2015. The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field. Hamostaseologie. 35:128–136.
- Li RJ, Yang M, Li JF, Xue L, Chen YG, Chen WQ. 2014. Circulating CD36 and fractalkine levels are associated with vulnerable plaque progression in patients with unstable angina pectoris. Clin Exp Pharmacol Physiol. 41:863–869.
- Rao VH, Kansal V, Stoupa S, Agrawal DK. 2014. MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells. Physiol Rep. 2:e00224.
- Jia F, Wu C, Chen Z, Lu G, Sun J. 2016. Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice. Mol Med Rep. 13:3574–3580.
- Alexander MR, Knowles JW, Nishikimi T, Maeda N. 2003. Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A−/− apolipoprotein E−/− mice. Arterioscler Thromb Vasc Biol. 23:1077–1082.
- Mehta PK, Christen P. 1993. Homology of pyridoxal-5′-phosphate-dependent aminotransferases with the cobC (cobalamin synthesis), nifS (nitrogen fixation), pabC (p-aminobenzoate synthesis) and malY (abolishing endogenous induction of the maltose system) gene products. Eur J Biochem/FEBS. 211:373–376.
- Phillips RS. 2011. Structure, mechanism, and substrate specificity of kynureninase. Biochim Biophys Acta. 1814:1481–1488.
- Heyes MP, Rubinow D, Lane C, Markey SP. 1989. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann Neurol. 26:275–277.
- Lima S, Kumar S, Gawandi V, Momany C, Phillips RS. 2009. Crystal structure of the Homo sapiens kynureninase–3-hydroxyhippuric acid inhibitor complex: insights into the molecular basis of kynureninase substrate specificity. J Med Chem. 52:389–396.